How to balance prognostic factors in controlled phase II trials: randomization or minimization ? An analysis of clinical trials in digestive oncology

ANNÉE

2024

AUTEURS

Martin E, Le Malicot K, Guérin-Charbonnel C, Bocquet F, Bouché O, Turpin A, Aparicio T, Legoux JL, Dahan L, Taieb J, Lepage C, Dourthe LM, Pétorin C, Bourgeois V, Raoul JL, Seegers V

CONGRÈS/REVUE

Current Oncology

LIEN PUBLICATIONS ASSOCIÉES